Hyperhomocysteinemia and vascular access thrombosis in hemodialysis patients: a retrospective study av Saifan C, El-Charabaty E, El-Sayegh S

Hämta fulltext

Warfarin-induced calciphylaxis: a case report and review of literature av El-Sayegh S, Saifan C, El-Charabaty E, Saad M

Hämta fulltext

Effect of hepatitis C virus infection on erythropoiesis in patients on hemodialysis av Saifan C, El-Charabaty E, Kleiner M, El-Sayegh S

Hämta fulltext

Treatment of confirmed B12 deficiency in hemodialysis patients improves Epogen® requirements av Saifan C, Samarneh M, Shtaynberg N, Nasr R, El-Charabaty E, El-Sayegh S

Hämta fulltext

Cardiovascular safety - Update from up to 6 years of treatment with baricitinib in rheumatoid arthritis clinical trials av Weinblatt, M, Taylor, P, Burmester, G, Saifan, C, Walls, C, Issa, M, Rooney, T, Takeuchi, T

Cardiovascular safety during treatment with baricitinib in rheumatoid arthritis av Weinblatt, M, Taylor, P, Burmester, G, Witt, S, Saifan, C, Walls, C, Rooney, T, Chen, L, Takeuchi, T

Cardiovascular safety during treatment with baricitinib in rheumatoid arthritis av Taylor, P, Weinblatt, M, Burmester, G, Rooney, T, Witt, S, Walls, C, Issa, M, Salinas, C, Saifan, C, Zhang, X, Cardoso, A, Gonzalez-Gay, M, Takeuchi, T

Effects of proton pump inhibitors and electrolyte disturbances on arrhythmias av El-Charabaty E, Saifan C, Abdallah M, Naboush A, Glass D, Azzi G, Azzi Y, Khan A, Baydoun H, Rondla C, Parekh N, El-Sayegh S

Hämta fulltext

Lipid profile and effect of statin treatment in pooled phase II and phase III baricitinib studies av Taylor, PC, Kremer, J, Emery, P, Zuckerman, S, Ruotolo, G, Zhong, J, Chen, L, Witt, S, Saifan, C, Kurzawa, M, Otvos, JD, Connelly, MA, Macias, W, Schlichting, DE, Rooney, T, de Bono, S, McInnes, IB